Portfolio
Brands in Tandem.
Launching Rivfloza™ for the treatment of PH1 meant educating an HCP audience that was itself still learning.
PH1 is so rare that many specialists will never see a case. Its mechanism is complex, and its symptom patterns are often overlooked. For this strategic launch, Rivfloza™ would have to clarify the disease and make the case for its use in HCP practice.
The companion diagnostic NovoDETECT demanded a brand identity that could convey authority and accessibility in equal measure.
The assignment: Build two distinct identities for brands that must make each other stronger.
RIVFLOZA™ HCP LAUNCH CONCEPT
The brand voice had to simplify without condescending, and visual choice had to minimize any barrier to engagement.
Optimistic visual metaphor • Inviting pastel palette • Family vignettes • Plain-spoken copy
NovoDETECT HCP DIGITAL DOWNLOAD
NovoDETECT branding reflects a technical, rigorously informative tone and a clean, clinical design. Rather than simplify the science, the system pairs disciplined copy with clear information hierarchy to make complex diagnostic information easier to absorb.
Structured for scanning • Institutional palette • Icon-guided flow • Science-led writing